FDA places partial hold on BioNTech-MediLink ADC after multiple deaths - Endpoints News

The FDA placed an early-stage BioNTech trial on partial clinical hold after researchers observed multiple deaths, the company said in an SEC filing Monday. Regulators told BioNTech partner MediLink Therapeutics that an antibody-drug conjugate called BNT326/YL…